Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -1.49
- Piotroski Score 4.00
- Grade Buy
- Symbol (LUNG)
- Company Pulmonx Corporation
- Price $6.41
- Changes Percentage (3.39%)
- Change $0.21
- Day Low $6.12
- Day High $6.58
- Year High $14.84
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also provides StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 02/19/2025
- Fiscal Year End N/A
- Average Stock Price Target $10.00
- High Stock Price Target $20.00
- Low Stock Price Target $6.00
- Potential Upside/Downside N/A
- Consensus Rating Strong Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$1.54
- Trailing P/E Ratio -4.51
- Forward P/E Ratio -4.51
- P/E Growth -4.51
- Net Income $-60,843,000
Income Statement
Quarterly
Annual
Latest News of LUNG
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Toyota Plunges 20% in 6 Months: At a Low P/E, is TM Stock a Buy Now?
Toyota (TM) is currently undervalued with a forward P/E ratio of 7.6X, lower than the industry average and its own 5-year average. Despite recent challenges, including a profit decline and reduced sal...
By Yahoo! Finance | 1 day ago -
Qualcomm Shares Plunge 7% as Investors Question Bold Growth Projections Beyond Smartphones
Qualcomm's stock fell 7% following its Investor Day, where CEO Cristiano Amon outlined plans to expand into automotive and IoT markets. Despite ambitious revenue projections, investors are skeptical d...
By Yahoo! Finance | 1 day ago -
Santander UK profits plunge after £295m motor finance hit
Santander UK's profits plunged due to a £295 million provision for car finance commission payouts. The bank disagreed with a court ruling and announced job cuts. Mortgage lending and customer deposit...
By Yahoo! Finance | 1 day ago
